CJ Bioscience, Inc. (KOSDAQ:311690)

South Korea · Delayed Price · Currency is KRW

3,435.00

+5.00 (0.15%)

At close: Aug 3, 2026

CJ Bioscience Financials Overview

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	3,563	3,693	3,467	5,575	4,075	4,363
Revenue Growth	5.56%	6.52%	-37.82%	36.82%	-6.61%	-17.86%
Gross Profit	591.65	632.96	284.83	1,773	1,311	1,642
Operating Income	-23,531	-24,786	-34,241	-32,057	-33,233	-10,108
Net Income	-23,004	-24,005	-32,838	-22,913	-34,913	-19,272
Earnings Per Share	-1760.74	-1837.29	-3541.00	-3235.00	-5940.02	-4533.00
EPS Growth	-	-	-	-	-	-

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	44,130	50,839	75,309	64,095	49,324	80,080
Total Debt	10,612	10,411	9,351	8,533	28,966	23,891
Net Cash (Debt)	33,518	40,427	65,958	55,562	20,357	56,190
Net Cash Growth	-40.13%	-38.71%	18.71%	172.93%	-63.77%	1501.15%
Net Cash Per Share	2565.50	3094.21	7112.48	7843.75	3463.50	13214.21

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	-19,836	-23,416	-27,760	-24,899	-20,963	-8,437
Capital Expenditures	-10.66	-10.66	-377.59	-4,924	-4,145	-952.65
Free Cash Flow	-19,846	-23,427	-28,138	-29,823	-25,108	-9,390
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	16.61%	17.14%	8.22%	31.80%	32.19%	37.62%
Operating Margin	-660.47%	-671.24%	-987.76%	-575.00%	-815.61%	-231.68%
Pretax Margin	-645.68%	-650.10%	-947.28%	-410.99%	-856.84%	-441.72%
Profit Margin	-645.68%	-650.10%	-947.28%	-410.99%	-856.84%	-441.72%
FCF Margin	-557.05%	-634.44%	-811.70%	-534.93%	-616.19%	-215.22%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 4, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PS Ratio	12.60	32.98	38.03	26.38	41.84	65.56